CFO
Natco Pharma Limited
Equibles does not estimate personal net worth.
Ameet Parekh is recorded as CFO at Natco Pharma Limited. Ameet Parekh has spoken on 3 earnings calls across 1 company, most recently for Natco Pharma Limited on November 13, 2026. Natco Pharma Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Greetings to everyone, and thank you once again for joining us in today's earning call. The company recorded consolidated total revenues of 1,019.4 crores in quarter to FI 27 compared to Rs.”
“Greetings to everyone, and thank you once again for joining NACCOR's quarter 1 FY27 earnings call. The company recorded consolidated total revenues of Rs.794.4 crores in quarter 1 FI27 compared to Rs.1390.6 crores in the corresponding quarter last year.”
“So, yeah, the other expenses, largely this quarter, we had higher R&D expenses. And also, during the quarter, we had looked into some of the engineering spares and there were some write-downs.”
Natco Pharma Limited
CFO
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
Earnings Call
Natco Pharma Limited
Earnings Call for the Quarter Ended March 31, 2026
Natco Pharma Limited
